The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

August 2010

Volume 50, Issue 8

Pages 858–974

  1. Review

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Drug Interactions
    7. Brief Report
  2. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Drug Interactions
    7. Brief Report
    1. Impact of Target-Mediated Drug Disposition on Linagliptin Pharmacokinetics and DPP-4 Inhibition in Type 2 Diabetic Patients (pages 873–885)

      Ms Silke Retlich, Dr Vincent Duval, Dr Ulrike Graefe-Mody, Mr Ulrich Jaehde and Dr Alexander Staab

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009356444

  3. Pharmacodynamics

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Drug Interactions
    7. Brief Report
    1. Oritavancin, a New Lipoglycopeptide Antibiotic: Results From a Thorough QT Study (pages 895–903)

      Dr Borje Darpo, Dr Sun K. Lee, Dr Thomas E. Moon, Dr Nancy Sills and Dr Jay W. Mason

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009355449

    2. Correlation of Inhibition of Platelet Aggregation With Cardiovascular and Bleeding Outcomes in Acute Coronary Syndromes (pages 904–913)

      Dr Russ Wada, Dr Shashank Rohatagi, Dr David Small, Dr Kenneth J. Winters and Dr Daniel E. Salazar

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009353606

  4. Pharmacokinetics

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Drug Interactions
    7. Brief Report
    1. Comparison of the Gastrointestinal Absorption and Bioavailability of Fenofibrate and Fenofibric Acid in Humans (pages 914–921)

      Dr Tong Zhu, Dr Jean-Claude Ansquer, Dr Maureen T. Kelly, Dr Darryl J. Sleep and Dr Rajendra S. Pradhan

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009354995

    2. Permeability and Concentration of Levofloxacin in Epithelial Lining Fluid in Patients With Lower Respiratory Tract Infections (pages 922–928)

      Dr Jing Zhang, Dr Xin Xie, Dr Xin Zhou, Dr Yu-Qing Chen, Dr Ji-Cheng Yu, Guo-Ying Cao, Dr Xiao-Jie Wu, Dr Yao-Guo Shi and Dr Ying-Yuan Zhang

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009355160

    3. Genetic Variation in Metabolizing Enzyme and Transporter Genes: Comprehensive Assessment in 3 Major East Asian Subpopulations With Comparison to Caucasians and Africans (pages 929–940)

      Dr Michael Man, Dr Mark Farmen, Dr Carmen Dumaual, Dr Choo Hua Teng, Dr Brian Moser, Dr Shin Irie, Dr Gyu Jeong Noh, Dr Reuben Njau, Dr Sandra Close, Dr Stephen Wise and Dr Richard Hockett

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009355161

    4. Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers (pages 941–950)

      Dr Howard N. Bockbrader, Dr Louis L. Radulovic, Dr Edward L. Posvar, Dr James C. Strand, Dr Christine W. Alvey, Dr Janice A. Busch, Dr Edward J. Randinitis, Dr Brian W. Corrigan, Dr George M. Haig, Dr Rebecca A. Boyd and Dr David L. Wesche

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009352087

  5. Drug Interactions

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Drug Interactions
    7. Brief Report
    1. Ketoconazole and Rifampin Significantly Affect the Pharmacokinetics, But Not the Safety or QTc Interval, of Casopitant, a Neurokinin-1 Receptor Antagonist (pages 951–959)

      Dr Brendan M. Johnson, Dr Laurel M. Adams, Dr Ke Zhang, Dr Shelby D. Gainer, Dr Lyndon C. Kirby, Dr Robert A. Blum, Dr Glen Apseloff, Dr Royce A. Morrison, Dr MD and Dr Peter F. Lebowitz

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009353761

    2. Effect of the Proton Pump Inhibitor Esomeprazole on the Oral Absorption and Pharmacokinetics of Nilotinib (pages 960–967)

      Dr Ophelia Q. P. Yin, Dr Neil Gallagher, Dr Deirdre Fischer, Dr Eren Demirhan, Dr Wei Zhou, Dr Georg Golor and Dr Horst Schran

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009346061

  6. Brief Report

    1. Top of page
    2. Review
    3. Pharmacokinetics and Pharmacodynamics
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Drug Interactions
    7. Brief Report
    1. Interlaboratory Measurement Differences in Intracellular Carbovir Triphosphate Concentrations in HIV-Infected Patients: Sources of Variability in Processing, Shipping, and Quantitation (pages 968–974)

      Dr Miguel Goicoechea, Dr Sonia Jain, Dr Lucun Bi, Ms Shelly Sun, Dr Glenn Smith, Dr Belinda Ha, Dr Douglas Richman, Dr Stan Louie, Dr Richard Haubrich and The California Collaborative Treatment Group

      Version of Record online: 7 MAR 2013 | DOI: 10.1177/0091270009352186

SEARCH

SEARCH BY CITATION